Dr. Churukanti Linga Reddy is the president and chief scientific officer of BIO-VIN Group has extensive experience in synthesizing biologically active molecules, development of new synthetic methods, enzyme catalysis and designing of new inhibitors.
Dr. Linga Reddy started working in Dr Reddy’s Laboratories, in India as a Group leader. Process developed for various API’s (Enalopril, Captopril, Astemizole etc.) Later he joined as Post graduate research Chemist in the department of Chemistry, University of Califonia San Diego, USA in 1988 and worked on model synthetic studies of hemerythrin (a non heme metalloprotein oxygen carrier).
He also developed synthetic methodologies to construct 1,2-di imidazolyl aromatic ring systems. Further Dr Reddy joined as research faculty in the department of medicine, UC San Diego in 1990 and worked for four years in drug discovery program to develop bile acid absorption inhibitors as lowering of elevated blood cholesterol agents.
Dr Reddy then joined EMD (Merck KGA) Chemicals, San Diego division as a Sr. Scientist in 1994 and was involved in the design and synthesis of various bio chemicals such as inhibitors, calcium probes, detergents etc and developed many innovative methodologies for practical synthesis of new inhibitors.
He was then promoted as R&D Head of Chemistry department and was involved in designing various inhibitors and directing his group in the company. Dr. Reddy underwent many management trainings during his tenure as a head of the department. Dr Reddy obtained his Ph.D (Synthetic Organic Chemistry) from the University of Hyderabad during the year 1987.
Dr Reddy co founded Bio-Vin in 2008 and is presently the Chief Scientific officer of the company, driving the research for identifying and inventing new tools for drug discovery & Process development of Various APIs.